[HTML][HTML] Upregulated type I interferon responses in asymptomatic COVID-19 infection are associated with improved clinical outcome

KI Masood, M Yameen, J Ashraf, S Shahid… - Scientific reports, 2021 - nature.com
Understanding key host protective mechanisms against SARS-CoV-2 infection can help
improve treatment modalities for COVID-19. We used a blood transcriptome approach to …

[PDF][PDF] COVID-19 pandemic in Indonesia: Situation and challenges of rehabilitation medicine in Indonesia

B Nugraha, LK Wahyuni, H Laswati… - Acta Med …, 2020 - researchgate.net
ABSTRACT COVID-19 has become a pandemic in Indonesia since the first cases have been
positively diagnosed on 2 March 2020 in Depok. The cases have been increased gradually …

[HTML][HTML] Decreased availability of nitric oxide and hydrogen sulfide is a hallmark of COVID-19

P Dominic, J Ahmad, R Bhandari, S Pardue… - Redox biology, 2021 - Elsevier
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is involved in
a global outbreak affecting millions of people who manifest a variety of symptoms …

Attenuating the effects of novel COVID-19 (SARS-CoV-2) infection-induced cytokine storm and the implications

AB Rowaiye, OA Okpalefe… - Journal of …, 2021 - Taylor & Francis
The COVID-19 pandemic constitutes an arduous global health challenge, and the
increasing number of fatalities calls for the speedy pursuit of a remedy. This review …

Immunobiology and immunotherapy of COVID‐19: A clinically updated overview

A Esmaeilzadeh, R Elahi - Journal of cellular physiology, 2021 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is a new member of the
coronavirus family that can cause coronavirus disease 2019 (COVID‐19). COVID‐9 has …

[HTML][HTML] Call for action to address equity and justice divide during COVID-19

S Bhaskar, A Rastogi, KV Menon, B Kunheri… - Frontiers in …, 2020 - frontiersin.org
The coronavirus 2019 disease (COVID-19) is deepening the inequity and injustice among
the vulnerable communities. The current study aims to present an overview of the impact of …

Attenuation of clinical and immunological outcomes during SARS‐CoV‐2 infection by ivermectin

GD de Melo, F Lazarini, F Larrous, L Feige… - EMBO molecular …, 2021 - embopress.org
The devastating pandemic due to SARS‐CoV‐2 and the emergence of antigenic variants
that jeopardize the efficacy of current vaccines create an urgent need for a comprehensive …

Does COVID‐19 contribute to development of neurological disease?

AM Mahalakshmi, B Ray, S Tuladhar… - Immunity …, 2021 - Wiley Online Library
Background Although coronavirus disease 2019 (COVID‐19) has been associated primarily
with pneumonia, recent data show that the causative agent of COVID‐19, the coronavirus …

[HTML][HTML] Cardiovascular impact of COVID-19 with a focus on children: A systematic review

M Rodriguez-Gonzalez… - World journal of …, 2020 - ncbi.nlm.nih.gov
BACKGROUND Since the beginning of the pandemic, coronavirus disease-2019 (COVID-
19) in children has shown milder cases and a better prognosis than adults. Although the …

Neutrophil activation and neutrophil extracellular traps (NETs) in COVID‐19 ARDS and immunothrombosis

MC Cesta, M Zippoli, C Marsiglia… - European Journal of …, 2023 - Wiley Online Library
Acute respiratory distress syndrome (ARDS) is an acute inflammatory condition with a
dramatic increase in incidence since the beginning of the coronavirus disease 19 (COVID …